Form 4: United Therapeutics EVP Exercises, Sells Shares

United Therapeutics' EVP & General Counsel, Paul A. Mahon, exercised stock options and sold 11,000 shares of common stock under a pre-arranged 10b5-1 plan.

Summary

• Paul A. Mahon, Executive Vice President and General Counsel of United Therapeutics Corp (UTHR), reported transactions on November 26, 2025.
• The transactions involved the exercise of 11,000 stock options at an exercise price of $135.42 per share.
• Concurrently, 11,000 shares of common stock were sold in multiple trades at weighted average prices ranging from $483.0467 to $488.1317.
• These transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan, which was established on December 24, 2024.
• Following these transactions, Mr. Mahon directly beneficially owns 36,781 shares of United Therapeutics common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 plan. It does not inherently signal strong positive or negative sentiment about the company's future performance, but rather reflects an executive managing their personal equity holdings.

Positives

• The executive realized a significant profit from exercising options and selling shares, indicating a substantial gain on their equity compensation.
• The transactions were conducted under a pre-arranged 10b5-1 plan, which demonstrates a structured approach to managing equity holdings and reduces concerns about opportunistic trading.

Negatives

• The sale of 11,000 shares by a key executive, even under a 10b5-1 plan, represents a reduction in insider ownership, which some investors might interpret as a lack of confidence, though it is often for diversification or liquidity.

Future Outlook

NA

Industry Context

This is a routine insider transaction report and does not provide information directly related to broader industry trends or competitors.

Stakeholder Impact

• Shareholders: The transaction represents a reduction in direct insider ownership, which is a common occurrence for executives managing their compensation and personal finances. It is unlikely to have a significant impact on the company's overall valuation or investor confidence given its pre-planned nature.

Key Dates

Keywords

UTHR, insider trading, stock options, 10b5-1 plan, executive compensation, share sale